Welcome
|
Help
|
Contact Us
|
About EDGAR® Online
|
Login
Dashboard
Today
Company
Industry
Search
Screener
Analytics
Search Filings
Subscriber Login
User Name:
Password:
Remember me on this computer
[
Forgot Your Password?
] [
Click Here to Subscribe
]
Recent Companies
-Select One-
RLMD - RELMADA THERAPEUTICS, INC.
Company
Summary
Company Info
Risk Factors
(10-Q 11/07/24)
Auditor Opinion & Info
Company News
Industry
Transcripts
Stock Info
Last Trade
$3.26 (-0.14/-4.12%)
Interactive Charting
Financials
Balance Sheet
Income Statement
Cash Flow
Financial Ratios
Financial Comparison
SEC Filings
Last MD&A
(10-Q 11/07/24)
Last Quarterly Filing
(10-Q 11/07/24)
Last Annual Filing
(10-K 03/19/24)
Last Proxy Filing
(DEFA14A 04/09/24)
All Filings
(Excluding Insider)
All Filings
All Quarterly Filings
All Annual Filings
All Proxy Filings
SEC Comment Letters
and Correspondence
Ownership
Summary
Insider Trades
Latest Insider Filings
Institutional Holders
5% Ownership Filings
Company People
Executive Compensation
All Company People
Subscribe Now
to unlock all the Features!
Learn More
Get Company Summary for
*
Print
Add Summary to Dashboard
Add Filings Alert
RELMADA THERAPEUTICS, INC. (RLMD)
Summary
Latest Filings
View
Form
Filer
Received
Period
Download / Print
Actions
10-Q
RELMADA THERAPEUTICS, INC.
11/07/24
09/30/24
Subscribe Now
4
CASAMENTO CHARLES J
10/23/24
10/22/24
Subscribe Now
EFFECT
RELMADA THERAPEUTICS, INC.
09/13/24
Subscribe Now
4
TRAVERSA SERGIO
09/11/24
09/09/24
Subscribe Now
4
CASAMENTO CHARLES J
09/11/24
09/09/24
Subscribe Now
4
SHENOUDA MAGED
09/11/24
09/09/24
Subscribe Now
4
KELLY PAUL EDWARD
09/11/24
09/09/24
Subscribe Now
S-3
RELMADA THERAPEUTICS, INC.
08/30/24
Subscribe Now
10-Q
RELMADA THERAPEUTICS, INC.
08/07/24
06/30/24
Subscribe Now
8-K
RELMADA THERAPEUTICS, INC.
05/30/24
05/24/24
Subscribe Now
Institutional Holders
Total Number of Holders
97
% of Shares Outstanding
44.83%
Total Shares Held
13,526,614
Total Value of Holdings
$45,990,487.60
Net Activity
(608,941)
Latest Company News
Date
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
©
2024
EDGAR® Online LLC, a subsidiary of OTC Markets Group.
All rights reserved
Solutions for Corporations
Terms of Use
Privacy Statement
EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.
EPWWEB-EXT01